In high grade ovarian cancer, high expression of GGCT has been confirmed to correlate with poorer OS, and GGCT facilitates the progression of ovarian cancer by activating the PI3K/AKT/mTOR pathway (Li et al. 2018). The gene discussed is MTOR; the disease is ovarian carcinoma.